- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04993053
Use of Cemented TFNA Nail Augmentation in the Treatment of Trochanterian Rock Fractures (TFNA)
Use of Cemented TFNA Nail Augmentation in the Treatment of Trochanterian Rock Fractures in Patients Over 65 Years of Age
Intramedullary nailing is the standard treatment of trochanteric fractures. Mechanical failure such as cut-out and cut-through are associated with high rates of revision surgery, functional impairment and mortality. Augmentation of the implant have shown encouraging results in reducing the number of mechanical failures. The aim of the study was to evaluate the rate of mechanical failure of the cement augmented screws of TFNA nails.
A descriptive, retrospective, multi-operator, single-centre study was performed at our level 1 trauma centre. Patients were included if they were > 65 years of age, presented with a trochanteric fracture treated with an augmented TFNA nail. The primary outcome was fixation failure rate (cut-out or cut-through) at 3 and 6 postoperative months. Secondary endpoints were intraoperative data, clinical scores, and radiographic analysis.
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
-
Brest, Frankrike, 29609
- CHU de Brest
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- > 65 years of age
- a trochanteric fracture that occurred through a low-energy mechanism
- an augmented TFNA nail
Exclusion Criteria:
- pathological fracture
- open fracture
- hips with pre-existing deformities other than osteoarthritis
- a history of hip surgery
- an insufficient quantity of injected cement (< 3 mL).
Studieplan
Hur är studien utformad?
Designdetaljer
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Fixation failure rate (cut-out or cut-through)
Tidsram: change at 3 and 6 postoperative months
|
On X rays
|
change at 3 and 6 postoperative months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Visual Analogue Scale score
Tidsram: at 3 and 6 postoperative months
|
the minimum is 0 and maximum 10, higher scores mean a worse outcome.
|
at 3 and 6 postoperative months
|
|
analysis evaluating quality of reduction
Tidsram: once
|
On X rays
|
once
|
|
Augmentation volume
Tidsram: once
|
once
|
|
|
length of surgery
Tidsram: at 3 and 6 postoperative months
|
at 3 and 6 postoperative months
|
|
|
radiation exposure
Tidsram: once
|
once
|
|
|
duration of hospitalisation
Tidsram: once
|
once
|
|
|
Intraoperative adverse events
Tidsram: once
|
once
|
|
|
EuroQoL 5-Dimensions score
Tidsram: change at 3 and 6 postoperative months
|
the minimum is 5 and maximum 15, higher scores mean a worse outcome.
|
change at 3 and 6 postoperative months
|
|
Parker Mobility Score
Tidsram: at 3 and 6 postoperative months
|
the minimum is 0 and maximum 9, higher scores mean a better outcome.
|
at 3 and 6 postoperative months
|
|
Harris Hip Score
Tidsram: at 3 and 6 postoperative months
|
the minimum is 0 and maximum 100, higher scores mean a betteroutcome.
|
at 3 and 6 postoperative months
|
|
the tip-apex distance
Tidsram: once
|
On X rays
|
once
|
|
TFNA screw position
Tidsram: once
|
On X rays
|
once
|
|
distribution of cement on either side of the cervicocephalic screw
Tidsram: once
|
On X rays
|
once
|
|
postoperative complications
Tidsram: at 3 and 6 postoperative months
|
at 3 and 6 postoperative months
|
|
|
the need for revision surgery
Tidsram: at 3 and 6 postoperative months
|
at 3 and 6 postoperative months
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- TFNA - 29BRC21.0076
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Tidsram för IPD-delning
Kriterier för IPD Sharing Access
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .